Nemes Rush Group LLC TITAN PHARMACEUTICALS INCORPORATED DEL COM NEW Call Options Transaction History

Nemes Rush Group LLC

  • $689 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email